Conference report of the Digestive Disease Week (DDW) 2020
- FTRD® System: EFTR enables new therapeutic options for the treatment of lesions and is a feasible and safe modality, which leads to a high R0 resection rate
- First clinical cases with LiftUp® reveal promising results, proving it as valuable, safe and fast
- OTSC® shows superiority & cost-effectiveness over standard therapy for first-line UGIB and shows high success rates in the management of non-acute, full-thickness gastrointestinal defects
The conference of the Digestive Disease Week (DDW) 2020 scheduled for May 2-5, 2020 in Chicago, had to be cancelled due to the current situation. However, many scientific publications on Ovesco products were submitted this year again. The most important abstracts on Ovesco products are summarized in the report attached below.
For further information see:
Conference Report of DDW 2020